The Blog


Australian Businesses Beware! – First formal enforcement notice issued under the GDPR

Just when the initial panic surrounding the implementation of the GDPR has subsided, the UK Information Commissioner’s Office (ICO) has recently issued its first enforcement notice and to a foreign company at that! AggregateIQ Data Services Limited (AIQ), a data analytics firm operating out of Canada, was issued with the notice, which requires the company… Read more


Has there been a better time to invest in biotech?

AusBiotech described 2017 as the best year yet for the biotech industry in Australia.  The $500 million Biomedical Translation Fund (‘BTF’) has been a key driver of investment into the sector, announcing its first investment in May 2017 and four more in the backend of last year, with a total value of around $40 million.… Read more


In the age of ‘Big Data’, will your business be compliant with the Privacy Act come 22 February 2018?

We’re all beginning to understand that data is critical to decision making and as the age of ‘Big Data’ draws closer, the ability to collect and store information on individuals is becoming increasingly important. Businesses seeking to capitalise on the value of this information may not realise that obtaining it comes with obligations to protect… Read more


Related Party Benefits –could you be involved in a breach of the Act?

Gerry Cawson and Mark Ferraretto consider how to avoid being involved in an improper transaction. The Corporations Act regulates how public companies deal with entities related to them, including their directors and those directors’ families.  But these related party provisions extend beyond public companies.  Anyone ‘involved’ in a ‘related party transaction’ can fall foul of… Read more


New Crowd Sourced Equity Funding (why things may get confusing)

On 29 September 2017 new crowd sourced equity funding legislation will come into force.  This will allow public companies to utilise crowd sourced equity funding.  Although the ink isn’t even dry, the Government has already announced that it proposes to change the legislation to open up crowd sourced equity funding to proprietary companies. While this… Read more


Finding calm amongst the storm: Commercialisation in biotech

Just like a ship trying to navigate stormy waters, the biotechnology environment can be dangerous! Biotechs looking to commercialise their ideas need to be able to respond to a rapidly changing environment that is influenced by globalisation, increased market competition, financial pressures and the advancement of new technologies. What do you need to do to… Read more


Why dispute resolution clauses are the unsung hero of your deal

When making deals the commercial focus is directed to the nature of the transaction and how it works mechanically. Frankly speaking, ‘peripheral’ terms such as dispute resolution clauses are an afterthought. More often than not a standard clause for dispute resolution is used without much consideration. Unfortunately, this can mean that if a dispute arises,… Read more